JPMorgan Chase & Co’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Sell |
4,338,403
-571,368
| -12% | -$1.98M | ﹤0.01% | 1913 |
|
|
2025
Q1 | $12.9M | Sell |
4,909,771
-68,672
| -1% | -$180K | ﹤0.01% | 2008 |
|
|
2024
Q4 | $20.5M | Sell |
4,978,443
-539,073
| -10% | -$2.22M | ﹤0.01% | 1736 |
|
|
2024
Q3 | $39.1M | Buy |
5,517,516
+1,554,115
| +39% | +$11M | ﹤0.01% | 1313 |
|
|
2024
Q2 | $25.8M | Buy |
3,963,401
+246,133
| +7% | +$1.6M | ﹤0.01% | 1497 |
|
|
2024
Q1 | $30.9M | Sell |
3,717,268
-2,348,327
| -39% | -$19.5M | ﹤0.01% | 1431 |
|
|
2023
Q4 | $66.8M | Buy |
6,065,595
+929,111
| +18% | +$10.2M | 0.01% | 981 |
|
|
2023
Q3 | $43.2M | Buy |
5,136,484
+141,579
| +3% | +$1.19M | ﹤0.01% | 1073 |
|
|
2023
Q2 | $62.7M | Buy |
4,994,905
+694,079
| +16% | +$8.72M | 0.01% | 944 |
|
|
2023
Q1 | $70.8M | Sell |
4,300,826
-169,072
| -4% | -$2.78M | 0.01% | 866 |
|
|
2022
Q4 | $66.8M | Sell |
4,469,898
-548,589
| -11% | -$8.2M | 0.01% | 868 |
|
|
2022
Q3 | $112M | Buy |
5,018,487
+76,225
| +2% | +$1.71M | 0.02% | 634 |
|
|
2022
Q2 | $82.8M | Buy |
4,942,262
+1,667,873
| +51% | +$27.9M | 0.01% | 767 |
|
|
2022
Q1 | $98M | Sell |
3,274,389
-92,923
| -3% | -$2.78M | 0.01% | 792 |
|
|
2021
Q4 | $103M | Buy |
3,367,312
+1,940,330
| +136% | +$59.6M | 0.01% | 796 |
|
|
2021
Q3 | $45M | Buy |
1,426,982
+3,655
| +0.3% | +$115K | 0.01% | 1123 |
|
|
2021
Q2 | $52.1M | Buy |
1,423,327
+43,821
| +3% | +$1.6M | 0.01% | 1110 |
|
|
2021
Q1 | $47.7M | Buy |
1,379,506
+88,977
| +7% | +$3.08M | 0.01% | 1090 |
|
|
2020
Q4 | $53.6M | Buy |
1,290,529
+76,091
| +6% | +$3.16M | 0.01% | 941 |
|
|
2020
Q3 | $48.6M | Buy |
+1,214,438
| New | +$48.6M | 0.01% | 905 |
|